MedTrace Logo

Effects of a Dietary Supplement Containing L-Arabinose and Trivalent Patented Food-source of Chromium on Blood Glucose and Insulin

NCT01107431 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 70

Last updated 2011-05-13

No results posted yet for this study

Summary

This study was designed to examine changes in capillary blood glucose and venous insulin levels after a 70 gram oral sucrose challenge with and without simultaneous consumption of a dietary supplement containing L-Arabinose and a patented version of chromium (LA-Cr).

Conditions

  • Pre-diabetes

Interventions

DIETARY_SUPPLEMENT

L-Arabinose and Chromium

Consumed 70 grams of sucrose simultaneously taking a dietary supplement

DIETARY_SUPPLEMENT

Sucrose without dietary Supplement

Repeated measures on subjects taking 70 grams of sucrose along with taking a dietary supplement containing L-Arabinose and Chromium

Sponsors & Collaborators

  • Integrative Health Technologies, Inc.

    lead NETWORK

Principal Investigators

  • Gilbert R Kaats, PhD · Integrative Health Technologies

  • Harry G Preuss, MD · Georgetown University

Study Design

Allocation
NON_RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2008-12-31
Primary Completion
2009-12-31
Completion
2009-12-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01107431 on ClinicalTrials.gov